Serina Therapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2018 | $-2.0M | $-2.0M | $1.0K | $145.0K |
| Jun 2018 | $-2.2M | $-2.2M | $12.0K | $231.0K |
| Sep 2018 | $-1.8M | $-1.8M | $8.0K | $210.0K |
| Dec 2018 | $-2.0M | $-2.0M | $0 | $699.0K |
| Mar 2019 | $-2.6M | $-2.6M | $3.0K | $481.0K |
| Jun 2019 | $-2.8M | $-2.9M | $106.0K | $515.0K |
| Sep 2019 | $-2.4M | $-2.6M | $237.0K | $491.0K |
| Dec 2019 | $-2.4M | $-2.7M | $295.0K | $420.0K |
| Mar 2020 | $-2.1M | $-2.1M | $4.0K | $252.0K |
| Jun 2020 | $-2.2M | $-2.2M | $4.0K | $252.0K |
| Sep 2020 | $-1.9M | $-1.9M | $12.0K | $227.0K |
| Dec 2020 | $-1.6M | $-1.6M | $0 | $178.0K |
| Mar 2021 | $-2.6M | $-2.6M | — | $178.0K |
| Jun 2021 | $-1.7M | $-1.7M | — | $286.0K |
| Sep 2021 | $-1.9M | $-1.9M | — | $272.0K |
| Dec 2021 | $-1.6M | $-1.6M | — | $263.0K |
| Mar 2022 | $-1.6M | $-1.6M | — | $239.0K |
| Jun 2022 | $-1.7M | $-1.7M | — | $198.0K |
| Sep 2022 | $-1.2M | $-1.2M | — | $209.0K |
| Dec 2022 | $-1.3M | $-1.3M | — | $114.0K |
| Mar 2023 | $-709.0K | $-709.0K | — | $2.0K |
| Jun 2023 | $-864.0K | $-864.0K | — | $23.0K |
| Sep 2023 | $-1.0M | $-1.0M | — | $0 |
| Dec 2023 | $121.0K | $121.0K | — | $0 |
| Mar 2024 | $-1.6M | $-1.6M | $14.0K | $53.0K |
| Jun 2024 | $-8.0M | $-8.0M | $0 | $458.0K |
| Sep 2024 | $-3.0M | $-3.0M | $3.0K | $1.1M |
| Dec 2024 | $-4.6M | $-4.6M | $5.0K | $988.0K |
| Mar 2025 | $-4.3M | $-4.3M | $0 | $956.0K |
| Jun 2025 | $-3.8M | $-3.8M | $46.0K | — |
| Sep 2025 | $-3.9M | $-3.9M | $13.0K | — |
| Dec 2025 | $-6.0M | $-6.0M | $0 | — |
| Mar 2026 | $-4.6M | $-4.6M | $25.0K | — |
| Jun 2026 | $-6.7M | $-6.7M | $28.0K | — |